Bortezomib will improve the degree or result of flibanserin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. Enhanced flibanserin adverse effects could occur if coadministered with a number of weak CYP3A4 inhibitors. levoketoconazole will raise the amount or outcome of bortezomib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.... https://judyu009hsd2.tkzblog.com/profile